Jesus Perez

Dr. Jesus Perez


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
JPJesus Perez
Jesus Perez
RLRosalba León-Díaz
Rosalba León-Díaz
ADALEJANDRO ZENTELLA DEHESA
ALEJANDRO ZENTELLA DEHESA
ELEdmundo Lamoyi
Edmundo Lamoyi
MEMarcela Esquivel
Marcela Esquivel
Tania Romo-GonzálezTania Romo-González
Tania Romo-González
Breast cancer (BC) is the most frequent malignant neoplasia and leading cause of cancer mortality for women. A timely diagnosis of BC is crucial to ensure the best chances of survival. Among the various screening tools for BC, antibodies directed towards self-antigens or tumor-associated antigens (autoantibodies) have emerged as an alternative to image-based screening modalities. However, little attention has been paid to the global diversity of autoantibodies. This work aimed to analyze the diversity of autoantibodies reactive to antigens expressed by the BC cell line T47D in the sera of Mexican women with BC, benign breast pathology (BBP), or without breast pathology (WBP). We found that the diversity of antibodies in the sera was higher in the BC and BBP groups than in the WBP group. Likewise, the diversity changed with the progression of BC. Our results show and measure the complexity of the antibody response in breast health and disease.

6 September 2021 in Life
Verified
Journal Article
Open access
PDF file
JPJesus Perez
Jesus Perez
CRClarisa Retana
Clarisa Retana
EREspiridión Ramos-Martínez
Espiridión Ramos-Martínez
JCJosé Cruz-Colín
José Cruz-Colín
ASAndrés Saralegui-Amaro
Andrés Saralegui-Amaro
MVMaria Del Rosario Lopez Vancell
Maria Del Rosario Lopez Vancell
Amoebiasis in humans is caused by the protozoan parasite Entamoeba histolytica, which cytotoxic activity has been demonstrated on a wide variety of target cells. The process involves the adherence of the parasite to the cell, and such adherence is mediated by an amoebic surface lectin, known as Gal/GalNAc lectin. It is composed of heavy, intermediate, and light subunits. The carbohydrate recognition domain (CRD) has been identified within a cysteine-rich region in the lectin heavy subunit and has an amino acid sequence identity to the receptor-binding domain of hepatocyte growth factor (HGF). Recombinant CRD has been previously shown to compete with HGF for binding to the c-Met receptor IgG fusion protein. In the present study, we searched for evidence of interaction between the Gal/GalNAc lectin at the surface of trophozoites with the c-Met receptor expressed at the surface of HepG2 in coculture assays. Immunoprecipitation of the coculture lysate indicated interaction of the c-Met with a 60 kDa peptide recognized by antiamoebic lectin antibody. Colocalization of both molecules was detected by fluorescence confocal microscopy. Incubation of HepG2 cells with HGF before coculture with trophozoites prevents the cytotoxic effect caused by the parasites but not their adherence to the cells. Our results point to Gal/GalNAc lectin as a ligand of the c-Met receptor at the surface of HepG2 cells.